about
Highly pathogenic avian influenza virus (H5N1) outbreak in captive wild birds and cats, CambodiaNovel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase.Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibilityPrevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know?Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialMiddle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibilityIncidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, FranceEpidemiological Risk Factors for Animal Influenza A Viruses Overcoming Species Barriers.Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses.Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.Characterization of pandemic influenza immune memory signature after vaccination or infection.Host restriction of avian influenza viruses at the level of the ribonucleoproteins.Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections.Emerging highly pathogenic H5 avian influenza viruses in France during winter 2015/16: phylogenetic analyses and markers for zoonotic potential.Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes.Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France.Study of influenza A virus in wild boars living in a major duck wintering site.HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275YSpatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network.Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe.Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.Spread of avian influenza viruses by common teal (Anas crecca) in Europe.Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014.Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulationAttenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.High influenza a virus infection rates in Mallards bred for hunting in the Camargue, South of France.Guillain-Barré syndrome and influenza virus infection.The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expressionTen influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013Attenuated Mengo virus: a new vector for live recombinant vaccines.Introduction of SARS in France, March-April, 2003.Molecular cloning of the genome of poliovirus type 1Avian Influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection.
P50
Q24644944-AE1AFB4B-C369-4714-9CCA-3108A7616D2FQ27665921-B040990A-9902-4392-891D-2BFCDB980885Q27682247-357B4BDE-7875-407E-ADA0-71ACCB4CACE5Q28083816-4AA6C1DF-74AE-4FF6-A14E-F489A5AD5798Q28475986-BC28DE8A-B09A-4982-9300-3519AE031A95Q28660530-72B28173-132B-4B4F-857F-D057DE2EAEFFQ28730980-F59A9A15-3C3C-4CF9-8933-9A807C63AAFAQ30234415-849EC80F-2087-4D60-9815-724BF4F3A617Q30355533-689B2311-D7D9-42AB-B0AA-848C59BAAD80Q30360402-CA8D4B02-BCFF-453C-A74A-195B2BF0AD5DQ30363416-109EA6DB-D921-4449-88E4-7C48765D3A50Q30371993-C7CEE010-C717-486E-924E-21860895447FQ30378619-2FE737E4-3B22-4CA1-A3FF-72CCC0A25894Q30399688-B731C7E5-EAEB-489B-AC32-8D0BF128728CQ30402693-46632116-A216-41E9-86B9-1ECF168C123BQ30404407-BC41D9EA-AF15-46A9-945C-A3CB575C7633Q30409508-1D25DD52-0482-4E6D-BED0-437F48B51A21Q30411047-37D679CF-4B21-4D1B-89B4-C835F1AD1BF9Q30417891-616A06CE-0DF4-4579-840C-5B1E1DB67089Q30420516-FE9D4AB9-21FE-4BC4-A4FC-E87BB8DA88C8Q30420810-82E169D0-0836-4B6D-8380-3AD839B6B4FEQ30423877-4A29C1E5-7381-4C4F-A95C-76D39D8B04C0Q30432067-1BE3C904-CFF8-4DED-BEF7-A7B4C4AED1E1Q33247125-988EB335-0206-45A8-B428-66D53431AE68Q33354941-2AEB1592-592E-455A-8D91-CAF61856D308Q33508582-7E03ABF4-F866-49A0-8609-D7D3CEAAFE2EQ33521210-C99B532B-FD10-4255-9EC5-A2126F57B0CCQ33553247-08DA8762-654B-485C-8E13-B620A5E067B8Q33593103-6FEB24E6-91C3-4706-9DFA-81FD1345E8A7Q34277968-2CADC8F4-8E9D-441B-8939-BEAFC8A246D5Q34324295-88C45ABF-540C-41BF-BF6A-89859CB03C94Q34347979-7DF6206F-ADC2-492F-948E-76432E8AE064Q34405969-613BCA2A-D3E5-44F3-91BF-31EEE7D2028EQ34885906-EED35297-93C2-4EF5-866F-D226C5536AD2Q35069349-7297AF65-C0F3-46E7-BC9A-355D47508FC5Q35750762-D957B296-97EC-4110-86F6-08C10A6F399EQ35839164-8CB4482E-0F60-47EE-82B4-473474C5E355Q35879732-223CE168-F26B-4469-AA2A-408A61BA21EAQ36373085-989050E3-A343-48BB-9413-E9C8618D99E9Q37051652-F4C7F64B-C808-41F0-901A-D1BA1FD319F1
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Sylvie van der Werf
@ast
Sylvie van der Werf
@en
Sylvie van der Werf
@es
Sylvie van der Werf
@nl
type
label
Sylvie van der Werf
@ast
Sylvie van der Werf
@en
Sylvie van der Werf
@es
Sylvie van der Werf
@nl
prefLabel
Sylvie van der Werf
@ast
Sylvie van der Werf
@en
Sylvie van der Werf
@es
Sylvie van der Werf
@nl
P214
P106
P1153
7005851162
P21
P214
P31
P496
0000-0002-1148-4456
P5008
P735
P7859
viaf-203880656